NCT03461419 - Use of Stromal Vascular Fraction in Multiple Sclerosis | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

January 1, 2027

Study Completion Date

December 15, 2028

Conditions

Multiple SclerosisAutoimmune

Interventions

PROCEDURE

Microcannula Harvest Adipose Stroma

Use of Disposable, Closed Syringe Microcannula Harvest Autologous Adipose Stroma and Stem/Stromal Cells

DEVICE

Centricyte 1000

Centricyte 1000 closed system digestion of stromal vascular fraction to isolate and concentrate stem/stromal cells associated with microvasculature

PROCEDURE

Sterile Normal Saline IV Deployment of cSVF

Sterile Normal Saline Suspension cSVF in 500 cc for Intravenous Delivery Including 150 micron in-line filtration

Trial Locations (2)

Robert W. Alexander, MD, FICS, LLC, Stevensville

Global Alliance of Regenerative Medicine (GARM) International, Roatán